INTRODUCTION: Real-world evidence on the effects of direct oral anticoagulants (DOACs) in patients with cancer associated venous thromboembolism (VTE) is limited. Thus, our population-based cohort study …
Read moreOur Sponsors
Category: Targeted Research
Product Q & A From Our Major Sponsor
Q: I currently take 1 Boluoke® capsule a day as prescribed by my Lyme doctor a few years ago. I am currently healthy and no …
Read moreDirect Oral Anticoagulants May Be As Effective As Warfarin In Treating Left Ventricular Thrombosis
ABSTRACT: There are limited data from randomized controlled trials comparing rate control agents in atrial fibrillation. Patient-level data from the Atrial Fibrillation Follow-up Investigation of Rhythm …
Read moreAdding Aspirin to Direct Oral Anticoagulant Likely Increases the Risk of Bleeding Without Conferring Extra Thromboembolism Protection
IMPORTANCE: It is unclear how many patients treated with a direct oral anticoagulant (DOAC) are using concomitant acetylsalicylic acid (ASA, or aspirin) and how this …
Read moreProduct Q & A From Our Major Sponsor
Q: I was referred to one of the Canada RNA products by a colleague who was at the Hawaii ND convention recently and heard about …
Read moreDirect Oral Anticoagulants May Be As Effective As Warfarin In Treating Left Ventricular Thrombosis
AIM: To compare the safety and efficacy of direct oral anticoagulants (DOAC) relative to vitamin K antagonists (VKA) for the treatment of left ventricular thrombus (LVT). …
Read moreLp(a) 30 mg/dL is Associated with an Absolute Increase in CAC Volume
BACKGROUND: Elevated plasma lipoprotein (a) [Lp(a)] and coronary artery calcification (CAC) are established cardiovascular risk factors that correlate with each other. We hypothesized that other cardiovascular …
Read moreProduct Q & A From Our Major Sponsor
Q: Is there a currently available way to objectively determine if lumbrokinase is effective? I am aware of the references available on your web site. …
Read moreProphylactic or Therapeutic Use of Anticoagulants Appear to Reduce In-Hospital Mortality by about 50%
BACKGROUND: Thromboembolic disease is common in coronavirus disease-2019 (COVID-19). There is limited evidence on the association of in-hospital anticoagulation (AC) with outcomes and postmortem findings. …
Read moreConcomitant Treatment with NSAIDS Post MI Increases the Risk of Cardiovascular Events by Almost 700% and the Risk of Bleeding by 400%
BACKGROUND: Limited data are available regarding the risk for adverse clinical events with concomitant nonsteroidal anti-inflammatory drug (NSAID) treatment after myocardial infarction (MI). OBJECTIVES: The …
Read more